The rising cost of healthcare and its contribution to the worsening disease burden in developing countries.
作者信息
Fazal Faizan, Saleem Tayyaba, Ur Rehman Mohammad Ebad, Haider Tehseen, Khalid Abdul Rauf, Tanveer Usama, Mustafa Haris, Tanveer Junaid, Noor Arooba
机构信息
Department of Medicine, Rawalpindi Medical University, Block E Satellite Town, Rawalpindi, Pakistan.
出版信息
Ann Med Surg (Lond). 2022 Sep 15;82:104683. doi: 10.1016/j.amsu.2022.104683. eCollection 2022 Oct.
Abstract
摘要
相似文献
1
The rising cost of healthcare and its contribution to the worsening disease burden in developing countries.
Ann Med Surg (Lond). 2022 Sep 15;82:104683. doi: 10.1016/j.amsu.2022.104683. eCollection 2022 Oct.
2
3
Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy.
Adv Ther. 2021 Jan;38(1):441-467. doi: 10.1007/s12325-020-01536-2. Epub 2020 Nov 3.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.
6
Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries-A Cost-Effectiveness Analysis From Egypt.
Value Health Reg Issues. 2019 Sep;19:51-58. doi: 10.1016/j.vhri.2018.11.009. Epub 2019 Apr 16.
7
Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
J Prev Alzheimers Dis. 2021;8(3):362-370. doi: 10.14283/jpad.2021.17.
8
Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease.
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):130-9. doi: 10.1097/HJR.0b013e3282f19d42.
9
Burden of healthcare utilization and out-of-pocket costs among individuals with NCDs in an Indian setting.
J Community Health. 2013 Apr;38(2):320-7. doi: 10.1007/s10900-012-9617-1.
10
The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
Clin Drug Investig. 2011;31(8):543-557. doi: 10.2165/11589020-000000000-00000.
引用本文的文献
1
Are Hospital Pharmacists Ready for Precision Medicine in Nigerian Healthcare? Insights From a Multi-Center Study.
Health Care Sci. 2025 Apr 8;4(2):82-93. doi: 10.1002/hcs2.70008. eCollection 2025 Apr.
2
Disease-Agnostic Electronic Adherence Aid for Subcutaneous at-Home and Self-Administration Devices-The Lowest Common Denominator Based on a Cross-Indication Survey.
ACS Pharmacol Transl Sci. 2024 Apr 26;7(5):1310-1319. doi: 10.1021/acsptsci.3c00377. eCollection 2024 May 10.
3
Daily Consumption of Golden Berry () Has Been Shown to Halt the Progression of Insulin Resistance and Obesity in Obese Rats with Metabolic Syndrome.
Nutrients. 2024 Jan 26;16(3):365. doi: 10.3390/nu16030365.
4
Bibliometric Examination of Global Scientific Research about Carbapenem-Resistant (CRAB).
Antibiotics (Basel). 2023 Nov 4;12(11):1593. doi: 10.3390/antibiotics12111593.
5
Identifying key factors contributing to treatment costs for snakebite envenoming in private tertiary healthcare settings in Tamil Nadu, India.
PLoS Negl Trop Dis. 2023 Oct 16;17(10):e0011699. doi: 10.1371/journal.pntd.0011699. eCollection 2023 Oct.
本文引用的文献
1
Organisation of primary health care systems in low- and middle-income countries: review of evidence on what works and why in the Asia-Pacific region.
BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001487. doi: 10.1136/bmjgh-2019-001487. eCollection 2019.
2
Primary healthcare policy implementation in South Asia.
BMJ Glob Health. 2016 Sep 6;1(2):e000057. doi: 10.1136/bmjgh-2016-000057. eCollection 2016.
3
Expanding primary care in South and East Asia.
BMJ. 2017 Feb 27;356:j634. doi: 10.1136/bmj.j634.
4
Health equity: challenges in low income countries.
Afr Health Sci. 2009 Oct;9 Suppl 2(Suppl 2):S49-51.
5
Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial.
J Altern Complement Med. 2009 Jun;15(6):639-44. doi: 10.1089/acm.2008.0367.
6
Poverty and access to health care in developing countries.
Ann N Y Acad Sci. 2008;1136:161-71. doi: 10.1196/annals.1425.011. Epub 2007 Oct 22.
7
The double burden of communicable and non-communicable diseases in developing countries.
Trans R Soc Trop Med Hyg. 2006 Mar;100(3):191-9. doi: 10.1016/j.trstmh.2005.07.021. Epub 2005 Nov 4.
8
The global burden of chronic diseases: overcoming impediments to prevention and control.
JAMA. 2004 Jun 2;291(21):2616-22. doi: 10.1001/jama.291.21.2616.
9
Estimating the cost of using non-physician providers in primary care teams in an HMO: where would the savings begin?
HMO Pract. 1994 Dec;8(4):162-4.
10
Access to essential drugs in poor countries: a lost battle?
JAMA. 1999 Jan 27;281(4):361-7. doi: 10.1001/jama.281.4.361.
Zotero 插件